Curated News:

Medical Meetings

Add to Favorites Subscribe Share
fbshare-Medical Meetings

Showing results

2130 of 3636
mmc-logo.gif
  • Embargo expired:
    21-May-2019 6:00 PM EDT

Article ID: 713005

Mayo experts to present findings at Digestive Disease Week 2019

Mayo Clinic

Mayo Clinic researchers are among international experts who will present findings next week at Digestive Disease Week 2019, the world's largest gathering of physicians, researchers and industry leaders in gastroenterology and related fields.

Released:
17-May-2019 8:50 AM EDT
PAHandeye.jpg
  • Embargo expired:
    21-May-2019 5:00 PM EDT

Article ID: 712553

Microvascular Eye Disease May Help Lung Doctors See Vascular Damage in PAH

American Thoracic Society (ATS)

Retinal vascular tortuosity, a microvascular abnormality of the eye, may provide doctors with a noninvasive way of determining the extent of vascular remodeling in patients with pulmonary arterial hypertension,

Released:
13-May-2019 8:00 AM EDT
Olderwoman_copdasthma.jpg
  • Embargo expired:
    21-May-2019 4:45 PM EDT

Article ID: 712473

More Primary Care May Reduce Rates of Respiratory Failure

American Thoracic Society (ATS)

Increased use of primary care may reduce rates of respiratory failure and admissions to the intensive care unit, according to research presented at ATS 2019.

Released:
13-May-2019 8:00 AM EDT
patientwithtablet.jpg
  • Embargo expired:
    21-May-2019 3:15 PM EDT

Article ID: 712491

COPD Exacerbations May Decrease with Web-Based Intervention

American Thoracic Society (ATS)

COPD patients who were given a pedometer and participated in a web-based intervention that helped them set physical activity goals, provided feedback and disease self-management education, and offered a community forum were less likely to experience an acute exacerbation of their lung disease than those patients who received only the pedometer,

Released:
13-May-2019 8:00 AM EDT
ISPOR_KyleKlein_KKP_0791.jpg

Article ID: 713273

Medical Device Innovation and Regulation

ISPOR—The Professional Society for Health Economics and Outcomes Research

ISPOR, the professional society for health economics and outcomes research, started the day with the second plenary session of its ISPOR 2019 annual conference with, “Medical Device Innovation and Regulation: Turbocharged for Success?"

Released:
21-May-2019 3:05 PM EDT
COPD_pulmonaryrehab.jpg
  • Embargo expired:
    21-May-2019 11:00 AM EDT

Article ID: 712571

African Americans with COPD Appear Less Likely to Use Pulmonary Rehab

American Thoracic Society (ATS)

African American patients with chronic obstructive pulmonary disease, or COPD, are less likely to participate in pulmonary rehabilitation programs than white patients, even when there are programs nearby,

Released:
13-May-2019 8:00 AM EDT

Article ID: 713248

Sleep problems in teenagers reversed in just one week by limiting screen use

European Society of Endocrinology

Sleep in teenagers can be improved by just one week of limiting their evening exposure to light-emitting screens on phones

Released:
21-May-2019 10:05 AM EDT
ViH_Cover_No-ToC_2019-03.jpg

Article ID: 713216

20 Years of Value in Health

ISPOR—The Professional Society for Health Economics and Outcomes Research

ISPOR, the professional society for health economics and outcomes research (HEOR), examined the past 20 years of scientific publications in HEOR this afternoon at its ISPOR 2019 annual conference with the spotlight session issue panel [SP2], “Back to the Future in Value in Health.”

Released:
20-May-2019 4:35 PM EDT
Final_ISPOR_VERT-LG-01.png

Article ID: 713208

Growing Numbers of Orphan Drugs Challenge Health Plans

ISPOR—The Professional Society for Health Economics and Outcomes Research

ISPOR, the professional society for health economics and outcomes research (HEOR), explored the issue of orphan drug approvals and how they challenge health plans at its ISPOR 2019 annual conference this morning.

Released:
20-May-2019 3:35 PM EDT
smokers.jpg
  • Embargo expired:
    20-May-2019 3:15 PM EDT

Article ID: 712498

Smokers with Various Degrees of Lung Function Impairment Have Different Top Causes of Death

American Thoracic Society (ATS)

Current or former smokers with severe limitation in lung function are more likely to die from respiratory-related causes, while deaths from heart disease and lung cancer are more common in smokers with milder limitation in lung function

Released:
13-May-2019 8:00 AM EDT

Showing results

2130 of 3636

Chat now!